ACKR2 is an important regulator of inflammation and we have previously reported marked upregulation of expression in skin and peripheral blood leucocytes in psoriasis [22] and SSc [23], and others have shown increased expression in chronic obstructive pulmonary disease [24] and post-myocardial infarction tissues [25]. This evidence concerns the gene ACKR2 and systemic sclerosis.